Wyszukaj projekt badawczy
113 Wyniki
Ufundowane przez członka IRDiRC = Członek Europejskiej Sieci Referencyjnej (ERN) =
Projekt badawczy

Cataluña
L'HOSPITALET DE LLOBREGAT
Mejorando la precisión diagnostica y las perspectivas terapéuticas en enfermedades pulmonares intersticiales
IDIBELL - Instituto de Investigación Biomédica de Bellvitge
Grupo de Investigación en Neumología

Bayern
MÜNCHEN
HCQ4Surfdefect : Hydroxychloroquin (HCQ) zur Behandlung der pädiatrischen interstitiellen Lungenerkrankung (ILD) -DE-
Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital
Christiane Herzog Ambulanz

WIEN
WIEN
Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With Severe Acute Respiratory Distress Syndrome and Veno-venous Extracorporeal Membrane Oxygenation: a Prospective, Randomized, Clinical Trial
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Allgemeine Anästhesie und Intensivmedizin

WIEN
WIEN
ALARM: Advisory Lead ARDS Respirator Management
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Allgemeine Anästhesie und Intensivmedizin

WIEN
WIEN
Systems medicine analysis of sarcoidosis by targeting mTOR in a co-clinical trial in patients and mice
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Dermatologie

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Démêler la physiopathologie POIKTMP pour la conception d'approches thérapeutiques
Institution: Information not provided - FR

AUVERGNE-RHONE-ALPES
BRON
Transmission génétique des formes familiales de sarcoidose
CHU de Lyon HCL - GH Est
Unité Médicale de Génétique des Cancers et des Maladies Multifactorielles

AUVERGNE-RHONE-ALPES
BRON
Transmission génétique des formes familiales de sarcoidose
CHU de Lyon HCL - GH Est-Hôpital Louis Pradel
Service de pneumologie

Berlin
BERLIN
Oberflächen-Elektromyographie bei Patienten mit Acute Respiratory Distress Syndrome (ARDS)
Charité - Universitätsmedizin Berlin (CBF)
Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin

Dél-Dunántúl
PECS
Wnt jelátvitel szerepének vizsgálata új terápiás és diagnosztikai célpontok azonosítására a LAM-ben
University of Pécs
Department of Pharmacological Biotechnology

JAPAN
KYOTO
Multiomics analyses integrating genome/transcriptome/metabolome to elucidate the pathology of rare intractable diseases
Kyoto University Graduate School of Medicine

JAPAN
SHIZUOKA
Development of cloud-based integrated database and interactive diagnosis system for improving diagnostic accuracy and providing evidence for idiopathic interstitial pneumonias
Hamamatsu University School of Medicine

Utrecht
NIEUWEGEIN
Genetische predispositie tot interstitiele longziekten en ziektevormen
St. Antonius Ziekenhuis, locatie Nieuwegein
Longcentrum

Suisse Romande
FRIBOURG
Repurposing of a clinically used poly(ADP-ribose) polymerase inhibitor for the experimental therapy of ARDS
Université de Fribourg
Département de Médecine

Washington
ADDRESS: NOT PROVIDED - US
Inhaled gm-csf therapy of autoimmune pulmonary alveolar proteinosis
Institution: Information not provided - US

TIROL
INNSBRUCK
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis - AT
Medizinische Universität Innsbruck
Pädiatrie I

WIEN
ADDRESS: NOT PROVIDED - AT
Pharmachild JIA registry: Pharmacovigilance In Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents And/Or Methotrexate. A Pediatric Rheumatology International Trials Organisation (PRINTO)/Pediatric Rheumatology European Society (PRES) Registry - AT
Institution: Information not provided - AT

WIEN
WIEN
STRIVE: A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Pädiatrische Nephrologie und Gastroenterologie

Ontario
KINGSTON
IIH-ECC: Idiopathic Infantile Hypercalcemia - European-Canadian Consortium -CA
Queen's University
Department of Biomedical and Molecular Sciences

Ontario
TORONTO
The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis
Hospital for Sick Children, Research Institute

Québec
MONTRÉAL
Mécanismes d'action de SMPD1 dans les infections pulmonaires bactériennes chez les patients souffrant de la maladie de Niemann-Pick type A/B
Meakins-Christie Laboratories

AUVERGNE-RHONE-ALPES
GRENOBLE
USIDNET: modélisation des variants granulomatose septique chronique X+CGD et des mutants super-oxydase Nox2 dans la lignée cellulaire PLB985 pour l'étude des processus d'activation de la NADPH oxydase
CHU de Grenoble et des Alpes - Institut de biologie et de pathologie
Centre Diagnostic et Recherche sur la Granulomatose Septique Chronique

AUVERGNE-RHONE-ALPES
LA TRONCHE
Les NADPH oxydases NOX dans la réponse inflammatoire: aspects physiopathologiques, mécanismes de régulation et modélisation
Université Grenoble Alpes (UGA) - Campus santé
GREPI : Groupe de Recherche et d'Etudes du Processus Inflammatoire

AUVERGNE-RHONE-ALPES
LA TRONCHE
Validation d'un nouveau concept de thérapie cellulaire par transfert de protéines dans la granulomatose septique, CGD-X
Université Grenoble Alpes (UGA) - Campus santé
GREPI : Groupe de Recherche et d'Etudes du Processus Inflammatoire

CENTRE-VAL DE LOIRE
TOURS
Ondes acoustiques et hélium / oxygène pour le traitement en aérosol de la fibrose pulmonaire idiopathique (IPF)
Faculté de Médecine, Université de Tours François Rabelais
Équipe Inserm 3 : « Aérosolthérapie et biothérapies à visée respiratoire »

GRAND-EST
STRASBOURG CEDEX
Maladie Rare Invisible et Scolarité des Enfants
ESPE de Strasbourg
Equipe Apprentissages, pratiques d'enseignement et d'éducation

ILE-DE-FRANCE
CRÉTEIL
Anomalies des protéines du surfactant dans les pathologies pulmonaires chroniques de l'enfant
Centre Hospitalier Intercommunal de Créteil
Service de pédiatrie - Hôpital de jour

ILE-DE-FRANCE
PARIS
ERADAS et ERAFI: développement et validation de scores d'activité et de retentissement fonctionnel dans la spondylarthrite juvénile
Hôpital Necker-Enfants Malades
Développement normal et pathologique du système immunitaire

ILE-DE-FRANCE
VILLEJUIF
Plateformes de transition : Comprendre les attentes des parents de jeunes porteurs de maladies rares
CLCC Institut Gustave Roussy
Equipe Epidémiologie des radiations, épidémiologie clinique des cancers et survie

Bayern
GAUTING
INSIGHTS-IPF: Register-Studie zur Versorgungsforschung von Patienten mit idiopathischer Lungenfibrose
Asklepios-Fachkliniken München-Gauting
Klinik für Pneumologie

Berlin
BERLIN
ICON: Langfristigen Verlauf der juvenilen idiopathischen Arthritis - Langzeitstudien in der Gesundheitsforschung
Deutsches Rheuma-Forschungszentrum Berlin
Forschungsbereich Epidemiologie

Berlin
BERLIN
JuMBO: Langzeitbeobachtung der Anwendung von Etanercept / MTX bei im Kindesalter erkrankten Patienten mit chronischer Arthritis
Deutsches Rheuma-Forschungszentrum Berlin
Forschungsbereich Epidemiologie

Berlin
BERLIN
ActiMON: Aktivitätsmonitoring bei Jugendlichen und jungen Erwachsenen mit rheumatischen und muskuloskelettalen Erkrankungen
Deutsches Rheuma-Forschungszentrum Berlin
Forschungsbereich Epidemiologie

Hessen
GIEßEN
KFO 309: Virus-induzierte Lungenverletzung: Pathobiologie und neue therapeutische Strategien : Die Rolle von Epithelialem Endoplasmatischen Riticulum (ER) Stress und Fibroblasten Wachstumsfaktor (FGF) bei der initiierung und Aggravierung der Lungenfibrose (LF) durch virale infektionen (P7)
Med. Klinik und Poliklinik II des UKGM am Standort Gießen
Schwerpunkt Pneumologie und Intensivmedizin - Fibrosierende Lungenerkrankungen

Nordrhein-Westfalen
MÜNSTER
ICON: Langfristigen Verlauf der juvenilen idiopathischen Arthritis - Langzeitstudien in der Gesundheitsforschung
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Rheumatologie und Immunologie

Nordrhein-Westfalen
SANKT AUGUSTIN
BIKER-Register: Langzeitbeobachtung der Wirksamkeit und Verträglichkeit einer Therapie mit Biologika bei Patienten mit einer Juvenilen Idiopathischen Arthritis
Asklepios Kinderklinik Sankt Augustin GmbH
Abteilung für Allgemeine Kinder- und Jugendmedizin

County Dublin
DUBLIN
Evaluating the role of TLR3 L412F in disease progression in idiopathic pulmonary fibrosis
Trinity College Dublin
Institute of Molecular Medicine

County Galway
GALWAY
Lending an ear: "iPeer2Peer" plus "Teens Taking Charge" Online Self-Management to empower children with arthritis
National University of Ireland Galway
Centre for Pain Research

EMILIA ROMAGNA
BOLOGNA
Valutazione combinata dei fluidi polmonari tramite ecografia e bioimpedenza elettrica transtoracica in neonati prematuri affetti da sindrome da distress respiratorio acuto del bambino
Policlinico S. Orsola-Malpighi - Area S. Orsola
Azienda Ospedaliero-Universitaria Policlinico S. Orsola-Malpighi

LIGURIA
GENOVA
Pharmachild: farmacovigilanza in pazienti affetti da artrite idiopatica giovanile, trattati con agenti biologici e/o Metotrexato
IRCCS Istituto G. Gaslini - Ospedale Pediatrico
U.O. Pediatria II

LIGURIA
GENOVA
I nuovi criteri di PRINTO per la classificazione dell'artrite idiopatica giovanile. Un progetto basato sull'evidenza scientifica per la revisione dei criteri della Lega Internazionale contro i reumatismi (ILAR)
IRCCS Istituto G. Gaslini - Ospedale Pediatrico
U.O. Pediatria II

LOMBARDIA
MILANO
Valutazione combinata dei fluidi polmonari tramite ecografia e bioimpedenza elettrica transtoracica in neonati prematuri affetti da sindrome da distress respiratorio acuto del bambino
ASST Grande Ospedale Metropolitano Niguarda
Ospedale Niguarda

LOMBARDIA
MILANO
Patogenesi e terapia della malattia granulomatosa cronica mediante trasferimento genico in cellule staminali ematopoietiche
Istituto San Raffaele Telethon per la Terapia Genica - TIGET
Unità di Ricerca Clinica

LOMBARDIA
MONZA
Valutazione dello stato nutrizionale nella fibrosi polmonare idiopatica: uno studio pilota
ASST Monza - Ospedale San Gerardo
Dipartimento Cardio-Toraco-Vascolare

LOMBARDIA
MONZA
Fibrosi cardiovascolare nella fibrosi polmonare idiopatica (CardioIPF)
ASST Monza - Ospedale San Gerardo
Dipartimento Cardio-Toraco-Vascolare

JAPAN
KYOTO
Discovery of novel therapeutic approach for Nakajo-Nishimura syndrome and Blau syndrome
Center for iPS Cell Research and Application, Kyoto University
Department of Clinical Application

JAPAN
TOKYO
Promotion of Japanese IgA nephropathy prospective cohort study to improve the reliability and validity of Japanese classifications of histological grade, clinical severity and dialysis induction risk; the development of treatment to protect high risk patients from progression to end-stage kidney disease
The Jikei University Hospital
Clinical Training Center

Andalucía
CÓRDOBA
Identificación de la heterogeneidad molecular asociada a la enfermedad cardiovascular, la evolución clínica y la respuesta terapéutica en patologías autoinmunes sistémicas
IMIBIC - Instituto Maimónides de Investigación Biomédica de Córdoba
GC05 - Grupo de investigación en enfermedades autoinmunes inflamatorias sistémicas y crónicas del aparato locomotor

Asturias
OVIEDO
Polimorfismos de respuesta en relación a pirfenidona y nintedanib en pacientes con fibrosis pulmonar idiopática
Hospital Universitario Central de Asturias
Servicio de Neumología

Baleares
PALMA DE MALLORCA
Terapia celular en un modelo experimental de fibrosis pulmonar con acortamiento de telómeros y caracterización de las MSC pulmonares en la FPI con acortamiento de telómeros
IdISBa - Fundació Institut d'Investigació Sanitaria Illes Balears
Grupo de investigación en Inflamación, reparación y cáncer en enfermedades respiratorias

Cantabria
SANTANDER
Caracterización de las bases moleculares de la vasculitis mediada por IgA
IDIVAL: Instituto de Investigación Marqués de Valdecilla
Grupo de Epidemiología genética y arterioesclerosis en enfermedades inflamatorias sistémicas

Cataluña
BARCELONA
Estudio de la fibrosis pulmonar mediante el "radio-transcriptoma": una nueva forma de evaluación de las enfermedades pulmonares intersticiales fibrosantes
Hospital Clínic de Barcelona
Servicio de Neumología y Alergia Respiratoria

Cataluña
BARCELONA
Estudio de los mecanismos de progresión a fibrosis pulmonar en pacientes con neumonitis por hipersensibilidad
Vall d'Hebron Institut de Recerca VHIR
Grupo de investigación en neumología

Cataluña
L'HOSPITALET DE LLOBREGAT
Caracterización de la fibrosis pulmonar telomérica y su regulación biológica
Hospital Universitari de Bellvitge
Servicio de Neumología

Madrid
ALCORCÓN
Descifrando el papel de factor-H related proteins en las enfermedades renales relacionadas con el complemento
Hospital Universitario Fundación Alcorcón
Servicio de Nefrología

Madrid
MADRID
Descifrando el papel de factor-H related proteins en las enfermedades renales relacionadas con el complemento
Instituto de Investigación Hospital 12 de Octubre
Grupo de investigación en Nefrología Clínica

Region Stockholm
STOCKHOLM
Programmerad eliminering av celler: molekylära mekanismer och roll vid patogenes och behandling av kronisk inflammation
Karolinska Institutet - Solna
The Institute of Environmental Medicine

Suisse Alémanique
BASEL
Fibrosis-specific lung progenitor cells: Role and therapeutic potential in Idiopathic Pulmonary Fibrosis
Universitätsspital Basel
Klinik für Pneumologie

Suisse Romande
LAUSANNE
Can mesenchymal stem cell exosomes serve as a treatment for idiopathic pulmonary fibrosis?
EPFL - Ecole Polytechnique Fédérale de Lausanne
EPFL SV ISREC UPDEPALMA - De Palma's lab

Greater London
LONDON
Sub-phenotyping in juvenile dermatomyositis (JDM), a rare and serious autoimmune childhood disorder, within the UK JDM Cohort and Biomarker Study: from phenotype to stratified treatments
GOSH NHS Foundatin Trust
Juvenile Dermatomyositis Research Centre

Washington
ADDRESS: NOT PROVIDED - US
Juvenile myositis
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Neuro-ophthalmic mechanisms of disease
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Drugs; germs; and joints: antibiotics; gut microbiota; and juvenile idiopathic arthritis
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Animal care: supporting research on pathogenesis and treatment of autoimmunity
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting jak3 in the treatment of autoimmune disease
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Acid sphingomyelinase and niemann-pick disease
Institution: Information not provided - US

WIEN
WIEN
Von AAV (ANCA-associated vasculitis) zu CKD (chronic kidney disease) - die Rolle von TenascinC
Medizinische Universität Wien
Klinisches Institut für Pathologie

WIEN
WIEN
Extracellular Vesicles (EV) as markers of active disease in AAV (ANCA-associated vasculitis) - AT
Medizinische Universität Wien
Klinisches Institut für Pathologie

WIEN
WIEN
Computer assisted morphometry of pathological changes in renal biopsies from patients with AAV (ANCA-associated vasculitis) - AT
TissueGnostics GmbH - Headquarter
TissueGnostics GmbH

GRAND-EST
ILLKIRCH-GRAFFENSTADEN
Cibler le récepteur de la vitamine D pour le traitement de maladies rares induites par calcitriose
Institut de génétique et de biologie moléculaire et cellulaire - IGBMC
Département Génomique fonctionnelle et cancer

Mecklenburg-Vorpommern
ROSTOCK
Biomarker der Niemann-Pick-Krankheit Typ C (NPC1/NPC2): Eine internationale, multizentrische, epidemiologische Studie
Centogene AG

FRIULI VENEZIA GIULIA
UDINE
Studio del ruolo del ripiegamento proteico nella patogenesi della malattia di Niemann-Pick tipo C: un possibile target terapeutico
Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" di Udine
Centro di Coordinamento Regionale per le Malattie Rare

FRIULI VENEZIA GIULIA
UDINE
Screening della malattia di Niemann Pick tipo C tra pazienti affetti con malattia psichiatrica con eziologia sconosciuta
Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" di Udine
Centro di Coordinamento Regionale per le Malattie Rare

LAZIO
ROMA
Targeting adenosine tone in Niemann Pick type C Disease
ISS - Istituto Superiore di Sanità
Centro Nazionale per la Ricerca e la Valutazione preclinica e clinica dei Farmaci

LAZIO
ROMA
Un nuovo approccio farmacologico e di identificazione di biomarcatori cellulari in pazienti con la Malattia di Niemann-Pick di tipo C
ISS - Istituto Superiore di Sanità
Dipartimento del Farmaco

PUGLIA
BARI
Fisiopatologia della Vasculite Crioglobulinemica HCV-correlata: analisi molecolare, immunologica e clinica
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Unità di Epatologia - Sezione di Medicina Interna e Oncologia Clinica

TOSCANA
PISA
Studio dei meccanismi cellulari della malattia di Niemann-Pick di tipo C e identificazione di terapie neuroprotettive
Fondazione "Gabriele Monasterio" - Consiglio Nazionale delle Ricerche CNR
Area della Ricerca

JAPAN
CHIBA
Pathological analysis and development ofan innovative therapeutic agent ofniemann-pick disease type C
Graduate School of Pharmaceutical Sciences, Chiba University
Laboratory of Chemical Pharmacology

JAPAN
KUMAMOTO
Developing new drugs for Niemann-Pick disease type C
Institute of Molecular Embryology and Genetics, Kumamoto University
Department of Cell Modulation

JAPAN
OSAKA
Developing the disease specific therapy for ANCA-associated vasculitis focused on immune regulatory factors in neutrophils
Osaka University Graduate School of Medicine
Department of Respiratory Medicine and Clinical Immunology

JAPAN
TOKYO
Multitiered study to address clinical questions for management of intractable vasculitides
Tokyo Women's Medical University

NORTE
PORTO
Transporte de proteínas lisossomais por vias independentes à manose 6-fosfato: estudos moleculares, bioquímicos e funcionais
Instituto Nacional de Saúde Dr. Ricardo Jorge - Porto
Unidade de Investigação & Desenvolvimento; Departamento de Genética

Andalucía
GRANADA
Biomarcadores en orina para el diagnóstico no invasivo de patología renal en enfermedades autoinmunes sistémicas
GENYO - Genómica e Investigación Oncológica
Grupo de Genética de enfermedades complejas

Cataluña
BARCELONA
Terapia correctora de splicing mediante oligonucleótidos anitsentido para la enfermedad de Niemann-Pick tipo C: estudio pre-clínico en un modelo murino
Universitat de Barcelona. Facultat de Biologia
Departamento de genética molecular humana

Glasgow
GLASGOW
Harnessing the power of integrated data to investigate environmental exposures on ANCA vasculitis risk, an unbiased approach -GB
Institute of Infection, Immunity and Inflammation, University of Glasgow
Institute of Infection, Immunity and Inflammation

Washington
ADDRESS: NOT PROVIDED - US
Therapeutics for rare and neglected diseases - science
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Development of neurosteroids for lysosomal storage disorders
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Genetic analysis of complex inflammatory disorders
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Genetic and genomic analysis of niemann pick type c1 disease
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Genetics and pathophysiology of systemic onset juvenile idiopathic arthritis
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Novel regulators of inflammatory arthritis and bone erosion
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Pathogenesis of behcet's disease and still's disease
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Clinical investigations of niemann-pick disease; type c
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Inborn errors of cholesterol synthesis
Institution: Information not provided - US

ILE-DE-FRANCE
PARIS
Apport d'une modélisation dans l'évaluation microéconomique des stratégies thérapeutiques dans la granulomatose de Wegener
CHU Paris Centre - Hôpital Cochin, Site Cochin
Service de Santé publique : Gestion des risques et qualité

Cataluña
BARCELONA
Perfil de expresión génica en linfocitos T CD4+ de pacientes con granulomatosis eosinofílica con poliangitis o Síndrome de Churg-Straus
Hospital Clínic de Barcelona
Servicio de Enfermedades Autoinmunes

Madrid
ADDRESS: NOT PROVIDED - ES
STRIVE: Registro observacional a largo término, multicéntrico, longitudinal, post-marketing, para evaluar a largo término la seguridad y efectividad de Humira (Adalimumab) en niños con artritis juvenil idiopática activa poliarticular o de curso poliarticular de moderada a severa
Institution: Information not provided - ES

Washington
ADDRESS: NOT PROVIDED - US
Nasal microbiome and host immunity in granulomatosis with polyangiitis
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Characterization of proteins and other molecules by mass spectrometry
Institution: Information not provided - US
Wieloośrodkowy projekt badawczy
- Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital
- Christiane Herzog Ambulanz
- Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital
- Christiane Herzog Ambulanz
- Ospedale San Giuseppe Multimedica
- Il Polmone.it - Malattie Rare Polmonari
- Fondazione IRCCS Policlinico San Matteo
- S.C. di Pneumologia
- Queen's University
- Department of Biomedical and Molecular Sciences
- Faculté de médecine - RTH Laënnec
- Métabolomique et maladies métaboliques
- CHU Dijon Bourgogne - Hôpital François Mitterrand
- Service de Pneumologie - Soins Intensifs, Appareillage Respiratoire
- Institut Cochin (INSERM U 1016 - CNRS UMR 8104)
- Département Génétique et Développement
- Med. Klinik und Poliklinik II des UKGM am Standort Gießen
- Schwerpunkt Pneumologie und Intensivmedizin - Fibrosierende Lungenerkrankungen
- Medizinische Hochschule Hannover
- Klinik für Pneumologie
- Istituto San Raffaele Telethon per la Terapia Genica - TIGET
- Unità di Ricerca Clinica
- Istituto San Raffaele Telethon per la Terapia Genica - TIGET
- Unità di Ricerca Clinica
- Medizinische Universität Wien
- Klinisches Institut für Pathologie
- Institut für Immunologie der Universität Münster
- Institut für Immunologie

Bayern
MÜNCHEN
CHILD-EU: Orphans Unite: chILD better together European Management Platform for Childhood Interstitial Lung Diseases

Bayern
MÜNCHEN
HCQ4Surfdefect : Hydroxychloroquine (HCQ) in pediatric ILD

LOMBARDIA
MILANO
Il Polmone.it - Malattie Rare Polmonari

LOMBARDIA
PAVIA
EuPAPNet: European pulmonary alveolar proteinosis network: molecular determinants of causes, variability and outcome

Ontario
KINGSTON
IIH-ECC: Idiopathic Infantile Hypercalcemia: European-Canadian Consortium

AUVERGNE-RHONE-ALPES
LYON
Réseau sur les maladies de surcharge lysosomales

BOURGOGNE-FRANCHE-COMTE
DIJON
SHOT-IPF: Traitement de la fibrose pulmonaire idiopathique par des inhibiteurs de petites HSPs

ILE-DE-FRANCE
PARIS
EUROAS: consortium européen pour les études génétiques et immunogénétiques de la spondylarthrite ankylosante et des autres spondylarthropathies

Hessen
GIEßEN
eurIPFnet: Europäisches IPF Netzwerk: natürlicher Verlauf, Pathomechanismen und neue Behandlungsmöglichkeiten für die idiopathische pulmonale Fibrose

Niedersachsen
HANNOVER
IPF-AE: Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Mechanism and Biomarkers

LOMBARDIA
MILANO
EURO-CGD: genetics and pathogenesis of chronic granulomatous disease and development of new gene transfer therapeutic approaches

LOMBARDIA
MILANO
CELL-PID: advanced cell-based therapies for the treatment of primary immunodeficiency

WIEN
WIEN
RELENT: RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities

Nordrhein-Westfalen
MÜNSTER